Oxcarbazepine as a neuroprotective agent in MS: a phase IIa trial (PROXIMUS)M. Marta,L. Bianchi, D. Lieberman,O. Ciccarelli,S. Collorone, R. Kapoor, J. Chataway,K. Schmierer,D. Baker,D. Altmann,G. GiovannoniMULTIPLE SCLEROSIS JOURNAL(2019)引用 3|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要